NEWS
To the project promoted by Fujita Academy and Keio University
to Establish Infrastructure for Social Implementation of Cellular Medicine for Regenerative and Gene Therapy in East Japan
TOKYO, May 29, 2024 - SINFONIA TECHNOLOGY CO., LTD. (TSE: 6507) has delivered 2 units of an automated cell-culture system CellQualia™ Intelligent Cell Processing (ICP)System to Keio University in March and finished Performance Qualification in April in this year. This device will play a role in the stable production and supply of high-quality cell medicines for the realization of regenerative medicine, which is highly expected to be a next-generation medical treatment.
Sinfonia have been developing next-generation smart automated cell culture systems in collaboration with Dr. Shin Kawamata, an international leader in the quality control of cell manufacturing (CEO, Cyto-Facto Inc., and Specially Appointed Professor, Kobe University). As an outcome of the collaboration, Sinfonia have succeeded in incorporating the concept of Quality by Design (QbD) into an automated cell culture system for the first time in the world. The system consistently monitors the entire culture process and manufactures the product while ensuring the quality of the process. This has enabled us to manufacture cellular medicine automatically while monitoring the process.
The development of this device has been completed in October 2021, and performance tests continued at both Sinfonia Kobe Solutions Laboratory and the UK Stem Cell Bank. Comparable data to Sinfonia and good performance at UK Stem Cell Bank demonstrate that the device is convenient and reliable. The results of these experiments were presented at Annual Meeting of the International Society for Cell and Gene Therapy held in Paris in May of 2023.
The system was installed in a new cell-based drug production facility on Research Gate Building4 floor of the Tonomachi Town Campus of Keio University. Keio University and Fujita Gakuen have concluded a partnership agreement for the social implementation of advanced medical technology and the promotion of industry-academia-public collaboration activities, mainly in the Haneda and Tonomachi areas. We expect that our equipment will make a significant contribution to the stable production and supply of high-quality cell medicines for regenerative medicine.
About SINFONIA TECHNOLOGY CO., LTD.
Sinfonia was established in 1917, with electromagnetic control technology as its core, providing various products including clean transport devices (semiconductors) and electrical components for space rockets and aircraft. They are based on our own technologies across four sectors: Clean Transport Systems, Power Electronics Equipment, Motion Equipment, and Engineering and Services. Today, Sinfonia applies these technologies cultivated in various fields and continues to contribute to further social progress by developing products used in sectors including Regenerative Medicine, Logistics, and Agriculture.
The company's revenues for the fiscal year 2023 (ended March 31, 2024) totaled 102.6 billion yen, with 3,683 consolidated employees.
###
For further information, please contact: HERE
This release is also published in the "News Release" section of the SINFONIA TECHNOLOGY CO., LTD. website.
RegMedNet is a community site for regenerative medicine and advanced medicine operated by Taylor & Francis Group. （https://www.regmednet.com/about/）
An April 3, 2023, article on the site entitled “Developing cell therapies with a stem cell robot” described that the UK Stem Cell Bank, a part of the UK's Medicines and Healthcare products Regulatory Agency (MHRA), introduced CellQualiaTM Intelligent Cell Processing (ICP) System for evaluation.
（https://www.regmednet.com/developing-cell-therapies-with-a-stem-cell-robot/）
This article was picked up as an industry topic followed a press release from the MHRA that appeared on the UK government website on March 16, 2023.
In addition, “RegMedNet's 2023 remix: top content of the year”, published on December 19, 2023, named our instrument's evaluation test at the UK Stem Cell Bank among the site's top 10 articles of 2023.
https://www.regmednet.com/regmednets-2023-remix-top-content-of-the-year/
We believe that this nomination represents the expectation to CellQualiaTM ICP System that the system contributes to improving manufacturing efficiency and stabilizing quality in the production of stem cells, which are the raw materials for cellular medicine manufacturing, and the spread of regenerative medicine will be accelerated by it. We will continue to strive to popularize the equipment so that various customers can stably manufacture high-quality cells.
2024.02.02
We are pleased to announce our participation in "ISCT 2024," where we will be showcasing the CellQualia™ Intelligent Cell Processing System.
We cordially invite you to visit our booth during the event.
ISCT 2024
International Society for Cell & Gene Therapy
Date: May 29 (Wednesday) - June 1 (Saturday), 2024
Venue: Vancouver Convention Centre, West Building
Booth: #820
Official Website: https://www.isctglobal.org/isct2024/home/
We look forward to welcoming you at our booth and sharing more about the CellQualia™ Intelligent Cell Processing System.
2023.04.06
We will have a booth at the iPSC Manufacturing Summit2023.
2023.5/2 (Tue) - 5/4 (thu)
Hilton Boston Back Bay(Boston, USA)
Press release
MHRA trialling pioneering stem cell robot that could transform the availability of life-saving cell therapies
The MHRA’s UK Stem Cell Bank is one of only two places in the world to test this technology.
click here to view the details
We will be exhibiting at the 4th Regenerative Medicine EXPO Tokyo and
introducing our automated cell culture system -CellQualia™ Intelligent Cell Processing System.
●4th Regenerative Medicine EXPO Tokyo
Dates] 13 (Wed) - 15 (Fri) July 2022, 10:00 - 18:00 (closing at 17:00 on the last day only)
Venue] Tokyo Big Sight, West Hall, 4F, Hall West-4, Booth 35-59
Invitation tickets are required for admission.
Organized by: RX Japan Ltd. (formerly Reed Exhibitions Japan Ltd.)
Supported by: The Japanese Society for Regenerative Medicine
We look forward to welcoming you.
We will have a web booth at the 21st Congress of the Japanese Society for Regenerative Medicine.
2022.3/17 (Thu) - 3/19 (Sat)
*To take part, please register online here.
The article "Realization of Quality By Design and Beyond: The Intelligent Cell Processing System" was published in Bioprocess International. Please read this article for a concrete explanation of the device culture based on the QbD concept.
Date and time: December 8(Wed.) - 10(Fri.) 2021 10:00-17:00
Venue: Makuhari Messe Hall 2, 21-47
To enter the exhibition, you need to pre-register on the official website.
At the venue, we will explain the equipment with AR video and other information.
We look forward to seeing you there.
2021.10.08
Date and time: October 13 (Wed.) - 15 (Fri.), 2021 10:00 - 17:00
Venue: Pacifico Yokohama Hall B, Kobe Biomedical Innovation Cluster(KBIC) Booth
To enter the exhibition, you need to pre-register on the official website.
At the venue, we will explain the equipment with video and other information.
We look forward to seeing you there.
CellQualia official SNS has opened.
We will keep you updated with the latest information from SNS. Please follow us.
Twitter: https://twitter.com/CellQualia
Linkedin: https://www.linkedin.com/company/75575323/
2021.09.29
"CellQualia" is the brand name for the regenerative medicine products of Symphonia Technology.CellQualia is a word we coined by combining the word "Cell" with the word "Qualia", which reminds us of quality.
The word "qualia" itself is defined as "a distinctive and vivid texture associated with sensory experience" (Kojien), but the word itself is derived from the Latin noun for "quality", "qualitas The origin of this word is the Latin noun "qualitas", which means "quality", and the brand name expresses our desire to focus on the quality of our cells.
With the CellQualia brand, we will continue to provide solutions that contribute to the production of high quality cells.
